Détail de l'auteur
Auteur J. MOUNTENEY |
Documents disponibles écrits par cet auteur (28)
Article : Périodique
P. GRIFFITHS ; J. MOUNTENEY ; D. LOPEZ ; F. ZOBEL ; W. GÖTZ |The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug-related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual ove[...]Rapport
Europol ; L. LANIEL ; C. CARPENTIER ; J. MOUNTENEY ; B. PALLAVICINI ; L. ROYUELA ; J. MATIAS ; R. KASECKER ; R. SEDEFOV ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Joint publications | 2011FRANÇAIS : L'OEDT et Europol publient une analyse conjointe concernant le marché des amphétamines. Leader dans la production des amphétamines, l'Europe est également une zone importante de consommation. ENGLISH: This joint publication with [...]Article : Périodique
L. MONTANARI ; B. GUARITA ; J. MOUNTENEY ; N. ZIPFEL ; R. SIMON |This paper explores European and national trends in specialised drug treatment entry for cannabis-related problems. The analysis is based on data for the years 2003-2014 from 22 European countries. Between 2003 and 2014, the overall number and p[...]Article : Périodique
J. MOUNTENEY ; P. GRIFFITHS ; A. CUNNINGHAM ; M. EVANS-BROWN ; M. FERRI ; D. HEDRICH ; A. NOOR |May 2016 saw the launch of the European Drug Report (EDR), the European Monitoring Centre for Drugs and Drug Addiction's (EMCDDA) annual review of the European drug situation, incorporating situational and trend analysis, statistical data and in[...]Périodique
J. MOUNTENEY | 1995FRANÇAIS : Les personnes qui se prostituent sont particulièrement dures à faire venir dans les centres traditionnels de soins aux toxicomanes. Cet article étudie l'exemple d'un organisme, Roma, qui a un statut de clinique. Roma est un centre qu[...]Article : Périodique
The internet facilitates rapid and covert communication, knowledge transfer, and has the potential to disrupt and transform drug market models and associated consumption patterns. Innovation and new trends diffuse rapidly through this medium and[...]Article : Périodique
I. GIRAUDON ; D. HEDRICH ; A. PIRONA ; A. NOOR ; J. MOUNTENEY |FRANÇAIS : Avec au moins 9 100 overdoses, ou décès provoqués par la drogue, en Europe en 2016 - en augmentation de 4% depuis 2015 - la consommation de drogues illicites représente un véritable défi de santé public (EMCDDA European Drug Report 2[...]Périodique
P. GRIFFITHS ; L. VINGOE ; N. HUNT ; J. MOUNTENEY ; R. HARTNOLL | 2000FRANÇAIS : Les SID (Systèmes d'Information sur les Drogues) offrent des données sur l'usage de drogues permettant ainsi une surveillance épidémiologique. Une typologie des SID existants est présentée. Les SID se distinguent par leur structure ([...]Livre
DrugScope ; G. HAYES ; H. SHAPIRO ; M. PLANT ; J. MOUNTENEY ; T. BENNETT ; R. COOMBER | London : DrugScope | 2000Livre
M. NILSON ; G. BURKHART ; C. KROGER ; H. WINTER ; O. BAKER ; J. MOUNTENEY ; NEAMAN R. | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 1998FRANÇAIS : Cette monographie reprend les conclusions de la première conférence européenne sur l'évaluation de la prévention contre la drogue. La première partie est centrée sur l'histoire, les fondements et l'évaluation de la recherche en mati[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; T. GROSHKOVA ; D. THANKI ; A. CUNNINGHAM ; M. RYCHERT | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014Concerns about the availability and use of methamphetamine in Europe have been growing for some time. Historically, the use of methamphetamine has been confined largely to the Czech Republic and Slovakia; however, recent signs of the spread of m[...]Rapport
P. BLANKEN ; C. CARPENTIER ; J. M. COSTES ; S. DIEMEL ; J. GAMELLA ; P. GRIFFITHS ; R. HARTNOLL ; N. HUNT ; J. MOUNTENEY ; C. MUTATAYI ; A. ALVAREZ ROLDAN ; J. SHERVAL ; R. SIMON ; L. VINGOE | Lisbon : OEDT / EMCDDA | 1999Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; M. EVANS-BROWN ; I. GIRAUDON | Lisbon : OEDT / EMCDDA | Technical reports | 2012The EMCDDA Trendspotter case study on Fentanyl in Europe was undertaken during September and October 2012. It culminated in an expert meeting in Lisbon on 9-10 October 2012. The aim of the study was to increase understanding of the availability [...]Article : Périodique
Fentanyl is a synthetic opioid analgesic historically used as a pain reliever and an anaesthetic. Recent concerns have arisen around the illicit use of fentanyl and its analogues in a number of European countries, linked to their high potency an[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; M. RUIZ ; A. BO ; T. GROSHKOVA ; J. MATIAS ; L. VANDAM ; F. CARDOSO ; R. CHRISTIE ; L. MONTANARI ; I. GIRAUDON ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2017This report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, including opioid and amphetamine injectors, prisoners, the homeless and men who have sex with[...]Rapport
OEDT = EMCDDA ; A. PIRONA ; L. MONTANARI ; I. GIRAUDON ; J. MATIAS ; K. OIEN ; L. VANDAM ; T. SURMONT ; B. GUARITA ; F. MATHIS ; J. MOUNTENEY ; K. NATONIEWSKA ; S. SLEIMAN ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Ad hoc publication | 2021Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and dru[...]Article : Périodique
May 2014 saw the launch of the European drug report (EDR), the European Monitoring Centre for Drugs and Drug Addiction's (EMCDDAs) annual review of the European drug market, incorporating trend analysis, topic overviews, statistical data and ind[...]Article : Périodique
T. SEYLER ; I. GIRAUDON ; A. NOOR ; J. MOUNTENEY ; P. GRIFFITHS |This paper addresses the question of whether Europe is facing an opioid epidemic and utilises data from the European monitoring system on opioid use, harms and availability, to help assess the situation. Data sources covering the last decade on [...]Article : Périodique
INTRODUCTION: Wastewater-based epidemiology (WBE) has emerged as a timely, non-invasive, and cost-effective indicator of illicit drug consumption. It is increasingly used by international organizations as a proxy measure for estimates of drug pr[...]Article : Périodique
J. MOUNTENEY ; M. STOOVE ; S. HAUGLAND |Within the drug trend monitoring arena, there is an increasing emphasis on the need for more timely identification and reporting of new patterns in drug consumption for policy-making purposes. However, there are documented problems with establis[...]Article : Périodique
A. PIRONA ; A. BO ; D. HEDRICH ; M. FERRI ; N. VAN GELDER ; I. GIRAUDON ; L. MONTANARI ; R. SIMON ; J. MOUNTENEY |Background: The availability of new psychoactive substances (NPS) in Europe has rapidly increased over the last decade. Although prevalence levels of NPS use remain low in the general European population, there are serious concerns associated wi[...]NouveautéRapport
OEDT = EMCDDA ; L. VANDAM ; P. BORLE ; L. MONTANARI ; T. SURMONT ; A. PIRONA ; D. HEDRICH ; A. GALLEGOS ; N. SINGLETON ; J. MOUNTENEY ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2018This report looks at the use of new psychoactive substances (NPS) in prison settings. This is a rapidly developing phenomenon, but empirical data are currently scarce and patchy. There is growing evidence that NPS are responsible for a large sha[...]Article : Périodique
J. MOUNTENEY ; P. GRIFFITHS ; A. BO ; A. CUNNINGHAM ; J. MATIAS ; A. PIRONA |This paper explores the recent resurgence in use of ecstasy/MDMA in Europe and highlights keys areas of continuity and divergence between the ecstasy market of the 1990s and the current MDMA market. Based on a scoping study involving a targeted [...]NouveautéPériodique
J. MOUNTENEY | 1996FRANÇAIS : La stratégie de lutte contre la drogue mis en place par le gouvernement britanique est en place depuis 2 ans. L'auteur, chercheur à l'ISDD donne une vue d'ensemble sur les différentes initiatives issues de cette stratégie telles que [...]Périodique
J. MOUNTENEY ; LEIRVAG S. E. | 2004ENGLISH : In 2002 the Bergen Clinics Foundation established Fore Var, a citywide 'earlier warning' system geared towards the identification, monitoring and reporting of drug and alcohol trends in the city of Bergen, Norway, on a six-monthly ba[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; A. BO ; A. CUNNINGHAM ; I. GIRAUDON ; J. MATIAS ; A. PIRONA ; N. VAN GELDER ; A. RYBARSKA ; L. VANDAM ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2016This report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European countries, and while overall the region’[...]Article : Périodique
The rapid growth in marketing cannabidiol poses a challenge to current European regulatory frameworks that can have important implications for consumer safety, public health, and established industries.Article : Périodique
C. COSTA STORTI ; A. L. BRETTEVILLE-JENSEN ; P. DE GRAUWE ; K. MOELLER ; J. MOUNTENEY ; A. STEVENS |The ongoing COVID-19 pandemic is likely to have a profound impact on the lives of high-risk drug users and on the services responding to their needs in at least two important ways: first, through the restrictive measures introduced to mitigate t[...]